TP53 and gastric cancer: For instance, silencing LRRC8A in gastric cancer cells increases the expression of p53 and several related genes, such as p21 (a CDK inhibitor induced by p53), Bcl-2 (an anti-apoptotic protein), and FAS (a death receptor), which together inhibit cell proliferation and promote apoptosis.